Feed

¹⁸F-FDG PET/CT imaging has transformed the way lymphoma patients are managed, playing a pivotal role in diagnosis, staging, prognostication, and treatment response evaluation. PET/CT guided treatment is a reality in HL, having spared patients from unnecessary toxicities while maximizing responses. Advancements in imaging technology and methodologies, along with the development of artificial intelligence, are expected to revolutionize the evaluation of complex imaging data, enhancing the diagnostic and predictive power of PET in lymphoma.